available only through 503A compounding pharmacies under physician supervision Typical research dose range / 200-800 mcg/day subcutaneously, cycled 4-8 weeks Known lethal dose (LD50) / Not established in any species studied to date Rodent acute toxicity ceiling / No mortality observed at doses exceeding 10 mg/kg intraperitoneally Most reported excess-dose symptoms / Nausea, lightheadedness, flushing, injection-site irritation Organ toxicity at supratherapeutic doses / Not demonstrated in published preclinical literature Antidote availability / No specific antidote exists
Candida overgrowth and Small Intestinal Bacterial Overgrowth (SIBO) are both forms of gut dysbiosis that cause overlapping symptoms bloating, gas, brain fog, fatigue, and food intolerances but they involve fundamentally different organisms and require different treatment approaches
In other words, in order to realize the ideal therapeutic effect, carnitine supplementation needs 250 mg/day for at least 14.4 weeks
At Perfect B, we use NAD injections rather than IV drips for most patients because the subcutaneous delivery is more practical in a protocol context and the bioavailability is reliable
Within the GI system, BPC-157 has been characterised across stomach, duodenum, small intestine, colon, and oesophagus in models of ulceration, NSAID toxicity, ethanol damage, inflammatory bowel disease, and anastomotic healing, Tendon and ligament research represents the second most extensively documented tissue application
It is also described in mechanistic contexts involving nitric oxiderelated pathways, growth factor expression, and cellular processes tied to migration and adhesionconcepts often studied when researchers are investigating how tissues respond and reorganize after experimental injury or stress
-1775582746855.png&w=384&q=75)
